Climb Bio reported earnings of -$ 0.18 per CLYM share on Nov 5, 2026, falling short of analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.20 |
| Earnings Per Share (Surprise) | -$ 0.18 (+$ 0.02) |
| Last Year's EPS | -$ 0.22 |
| EPS YoY Change |
Out of the last 32 earnings reporting periods, Climb Bio beat analysts’ expectations 8 times and fell short of expectations 10 time(s). Climb Bio reported earnings per share of -$ 0.18 in the last report surpassing an estimated EPS of -$ 0.20 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.20 | -$ 0.18 | -$ 0.19 | |
| Aug 6, 2026 | -$ 0.21 | -$ 0.18 | -$ 0.13 | |
| May 7, 2026 | -$ 0.26 | -$ 0.20 | -$ 0.31 | |
| Mar 5, 2026 | -$ 0.20 | -$ 0.26 | -$ 0.13 | |
| Nov 6, 2025 | -$ 0.16 | -$ 0.19 | -$ 0.13 | |
| Aug 12, 2025 | -$ 0.19 | -$ 0.13 | -$ 1.81 | |
| May 14, 2025 | -$ 0.15 | -$ 0.31 | -$ 0.06 | |
| Mar 25, 2025 | -$ 0.15 | -$ 0.13 | -$ 0.13 | |
| Nov 12, 2024 | - | -$ 0.13 | -$ 0.13 | |
| Aug 14, 2024 | - | -$ 1.81 | -$ 0.15 | |
| May 15, 2024 | - | -$ 0.06 | -$ 0.15 | |
| Mar 28, 2024 | -$ 0.13 | -$ 0.13 | -$ 0.19 | |
| Dec 31, 2023 | -$ 0.13 | -$ 0.13 | -$ 0.19 | |
| Nov 14, 2023 | -$ 0.14 | -$ 0.15 | -$ 0.84 | |
| Sep 30, 2023 | -$ 0.14 | -$ 0.15 | -$ 0.29 | |
| Aug 10, 2023 | -$ 0.16 | -$ 0.19 | -$ 0.29 | |
| Jun 30, 2023 | -$ 0.16 | -$ 0.19 | -$ 0.37 | |
| Mar 31, 2023 | -$ 0.25 | -$ 0.84 | -$ 0.37 | |
| Mar 6, 2023 | -$ 0.38 | -$ 0.29 | -$ 0.56 | |
| Dec 31, 2022 | -$ 0.38 | -$ 0.29 | -$ 0.50 |
Climb Bio’s stock was trading at $ 9.33 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, CLYM’s price increased to $ 10.29 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.18 | $ 9.33 | $ 10.29 | |
| Aug 6, 2026 | -$ 0.18 | $ 12.47 | $ 14.00 | |
| May 7, 2026 | -$ 0.20 | $ 12.22 | $ 11.37 | |
| Mar 5, 2026 | -$ 0.26 | $ 7.28 | $ 7.18 | |
| Nov 6, 2025 | -$ 0.19 | $ 1.92 | $ 1.83 | |
| Aug 12, 2025 | -$ 0.13 | $ 1.65 | $ 1.63 | |
| May 14, 2025 | -$ 0.31 | $ 1.27 | $ 1.20 | |
| Mar 25, 2025 | -$ 0.13 | $ 1.32 | $ 1.30 | |
| Nov 12, 2024 | -$ 0.13 | $ 4.06 | $ 3.53 |
Climb Bio released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Climb Bio beat analysts’ expectations during the last earnings period by
